Commentary: Keep FDA moving forward, not backward

When Vinay Prasad was tapped to lead the Food and Drug Administration’s Center for Biologics Evaluation and Research, the health care world braced for its effect. Known for his critical analyses of the FDA’s accelerated approval processes and calls for…